Literature DB >> 12612811

Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study.

Sofiane Maza1, Ray Valencia, Lilli Geworski, Andreas Zander, Hans Guski, Klaus J Winzer, Dieter L Munz.   

Abstract

The scintigraphic detection of sentinel lymph nodes (SNs) in early-stage breast cancer is a widely accepted diagnostic method. However, which radiotracer administration mode should be used is still controversial. This prospective study aimed to intra-individually compare the detection rates obtained after peritumoural versus subareolar injection with regard to SN number and localisation. Fifty-one women (age, 32-76 years) with breast cancer were investigated on two consecutive days. On day 1, 140-400 MBq technetium-99m nanocolloid was injected along the peripheral tumour margins. Static lymphoscintigrams of the axilla, thorax and neck were taken in various views 1 and 19 h p.i. On day 2, 10 MBq (99m)Tc-nanocolloid was injected subareolarly in the clock position of the tumour and dynamic and static scans were performed immediately. Thereafter, 30 MBq (99m)Tc-nanocolloid was administered peri-subareolarly and lymphoscintigrams were acquired in a dynamic and static manner. In 49/51 women, the different injection techniques disclosed the identical number and location of SNs in the axilla. In seven patients, the peritumoural injection detected additional SNs in the parasternal group. Axillary SNs were detected as early as 2-15 min following subareolar injection, both in the clock position and peri-subareolarly, as compared with about 1 h after peritumoural administration. Sixteen patients showed at least one tumour-positive SN, and nine also had tumour-positive non-SNs. One patient with a tumour-negative SN, visualised concordantly by both subareolar and peritumoural administration, demonstrated two metastatic non-SNs, yielding a false-negative rate of 5.9%. In conclusion, a simple subareolar injection in the clock position is sufficient for SN detection in breast cancer, if it is accepted that parasternal lymph node detection has no therapeutic consequences.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612811     DOI: 10.1007/s00259-003-1128-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  26 in total

1.  Subareolar injection is a better technique for sentinel lymph node biopsy.

Authors:  L F Smith; M J Cross; V S Klimberg
Journal:  Am J Surg       Date:  2000-12       Impact factor: 2.565

2.  Internal mammary node lymphoscintigraphy and biopsy in breast cancer.

Authors:  G Paganelli; V Galimberti; G Trifirò; L Travaini; C De Cicco; G Mazzarol; M Intra; P Rocca; G Prisco; U Veronesi
Journal:  Q J Nucl Med       Date:  2002-06

3.  The lymph drainage from the breast to the axillary and parasternal lymph nodes, studied with the aid of colloidal Au198.

Authors:  K A HULTBORN; L G LARSSON; I RAGNHULT
Journal:  Acta radiol       Date:  1955-01       Impact factor: 1.990

4.  Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.

Authors:  K A Kern
Journal:  J Am Coll Surg       Date:  1999-12       Impact factor: 6.113

5.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

Authors:  U Veronesi; G Paganelli; V Galimberti; G Viale; S Zurrida; M Bedoni; A Costa; C de Cicco; J G Geraghty; A Luini; V Sacchini; P Veronesi
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

6.  Subareolar versus peritumoral injection for location of the sentinel lymph node.

Authors:  V S Klimberg; I T Rubio; R Henry; C Cowan; M Colvert; S Korourian
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

7.  In search of the true sentinel node by different injection techniques in breast cancer patients.

Authors:  R M Roumen; L M Geuskens; J G Valkenburg
Journal:  Eur J Surg Oncol       Date:  1999-08       Impact factor: 4.424

8.  Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage.

Authors:  R A Valdés Olmos; P J Tanis; C A Hoefnagel; O E Nieweg; S H Muller; E J Rutgers; M L Kooi; B B Kroon
Journal:  Nucl Med Commun       Date:  2001-05       Impact factor: 1.690

9.  Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey.

Authors:  M A Warmuth; G Bowen; L R Prosnitz; L Chu; G Broadwater; B Peterson; G Leight; E P Winer
Journal:  Cancer       Date:  1998-10-01       Impact factor: 6.860

10.  Mammary lymphoscintigraphy in breast cancer.

Authors:  R F Uren; R B Howman-Giles; J F Thompson; D Malouf; G Ramsey-Stewart; F W Niesche; S B Renwick
Journal:  J Nucl Med       Date:  1995-10       Impact factor: 10.057

View more
  8 in total

1.  Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy.

Authors:  Rakhshanda Layeeque; Julie Kepple; Ronda S Henry-Tillman; Laura Adkins; Rena Kass; Maureen Colvert; Regina Gibson; Anne Mancino; Soheila Korourian; V Suzanne Klimberg
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

2.  Results of preoperative lymphoscintigraphy for breast cancer are predictive of identification of axillary sentinel lymph nodes.

Authors:  Frédéric Marchal; Philippe Rauch; Olivier Morel; Jean Claude Mayer; Pierre Olivier; Agnès Leroux; Jean Luc Verhaeghe; François Guillemin
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

3.  A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes.

Authors:  Narges K Tafreshi; Steven A Enkemann; Marilyn M Bui; Mark C Lloyd; Dominique Abrahams; Amanda S Huynh; Jongphil Kim; Stephen R Grobmyer; W Bradford Carter; Josef Vagner; Robert J Gillies; David L Morse
Journal:  Cancer Res       Date:  2010-12-17       Impact factor: 12.701

4.  Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer.

Authors:  Regina M Fearmonti; Isis W Gayed; Edmund Kim; Isabelle Bedrosian; Kelly K Hunt; Funda Meric-Bernstam; Barry Feig; Elham Ghonimi; Carla Warneke; Gildy V Babiera
Journal:  Ann Surg Oncol       Date:  2009-08-13       Impact factor: 5.344

5.  Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.

Authors:  Sofiane Maza; Anke Thomas; Klaus J Winzer; Christine Hüttner; Jens-Uwe Blohmer; Maik Hauschild; Matthias Richter; Thomas Krössin; Lilli Geworski; Andreas Zander; Hans Guski; Dieter L Munz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-27       Impact factor: 9.236

6.  The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis.

Authors:  Sarah Pesek; Taka Ashikaga; Lars Erik Krag; David Krag
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

7.  Molecular imaging of breast cancer lymph node metastasis.

Authors:  Narges K Tafreshi; Robert J Gillies; David L Morse
Journal:  Eur J Radiol       Date:  2012-09       Impact factor: 3.528

8.  Comparison of a 1-day and a 2-day protocol for lymphatic mapping and sentinel lymph node biopsy in patients with nonpalpable breast cancer.

Authors:  S van Esser; M Hobbelink; J W Van Isselt; W P Th M Mali; I H M Borel Rinkes; R van Hillegersberg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-25       Impact factor: 9.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.